Pitfalls in the Measurements and Assesment of Glomerular Filtration Rate and How to Escape them.

Oliver Rácz, Ján Lepej, Bertalan Fodor, Katarína Lepejová, Peter Jarčuška, Anna Kováčová, Hepameta Study Group

Abstract read

In one paragraph

Article in EJIFCC, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it

0cells of the map it votes in

4citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

Cardiovascular disease in older women with CKD.Clinical kidney journal · 2023
Article
Inflammaging and Vascular Function in Metabolic Syndrome: The Role of Hyperuricemia.Medicina (Kaunas, Lithuania) · 2022
Article
Acute Kidney Injury and Acute Respiratory Distress Syndrome.Critical care clinics · 2021
Review
Urinary chemical fingerprint left behind by repeated NSAID administration: Discovery of putative biomarkers using artificial intelligence.PloS one · 2020
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oliver RáczŠafárik University, Medical School, Department of Pathological Physiology, Košice, Slovakia; Miskolc University, Faculty of Healthcare, Department of Nanobiotechnology and Regenerative Medicine, Hungary; Cumulus Ltd., Laboratory of Clinical Chemistry, Košice, Slovakia.

Ján LepejInstitute of Nuclear and Molecular medicine , Košice, Slovakia.

Bertalan FodorMiskolc University, Faculty of Healthcare , Department of Nanobiotechnology and Regenerative Medicine, Hungary.

Katarína LepejováCumulus Ltd., Laboratory of Clinical Chemistry , Košice, Slovakia.

Peter Jarčuška1st Department of Internal Medicine, Šafárik University, Medical School, Košice , Slovakia ; Coordinator of the Hepameta Study Group.

Anna KováčováLabmed Ltd, (Medirex Group), Laboratory of Clinical Chemistry , Košice, Slovakia.

Hepameta Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27683410

PMCPMC4975241

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.